APO Research
Talk to an analyst

APO RESEARCH · REPORT

Varbenazine Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Varbenazine Capsules Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchVarbenazine Capsules Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Varbenazine Capsules Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Varbenazine Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Varbenazine Capsules Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Varbenazine Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Varbenazine Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Varbenazine Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Varbenazine Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Varbenazine Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Varbenazine Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Varbenazine Capsules include Lupin, Neurocrine Biosciences, Zydus, Sandoz and Teva Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Varbenazine Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Varbenazine Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Varbenazine Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Varbenazine Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Varbenazine Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Varbenazine Capsules sales, projected growth trends, production technology, application and end-user industry.

Varbenazine Capsules Segment by Company

Lupin

Neurocrine Biosciences

Zydus

Sandoz

Teva Pharmaceuticals

Varbenazine Capsules Segment by Type

80mg per Unit

60mg per Unit

40mg per Unit

Varbenazine Capsules Segment by Application

Hospital and Clinic

Pharmacy

Other

Varbenazine Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varbenazine Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Varbenazine Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varbenazine Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Varbenazine Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Varbenazine Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Varbenazine Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Varbenazine Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 80mg per Unit Major Manufacturers Table 3. 60mg per Unit Major Manufacturers Table 4. 40mg per Unit Major Manufacturers Table 5. Global Varbenazine Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital and Clinic Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Other Major Manufacturers Table 9. Varbenazine Capsules Industry Trends Table 10. Varbenazine Capsules Industry Drivers Table 11. Varbenazine Capsules Industry Opportunities and Challenges Table 12. Varbenazine Capsules Industry Restraints Table 13. Global Varbenazine Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Varbenazine Capsules Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Varbenazine Capsules Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Varbenazine Capsules Revenue Market Share by Region (2021-2026) Table 17. Global Varbenazine Capsules Revenue Market Share by Region (2027-2032) Table 18. Global Varbenazine Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Varbenazine Capsules Sales by Region (2021-2026) & (K Units) Table 20. Global Varbenazine Capsules Sales by Region (2027-2032) & (K Units) Table 21. Global Varbenazine Capsules Sales Market Share by Region (2021-2026) Table 22. Global Varbenazine Capsules Sales Market Share by Region (2027-2032) Table 23. Global Varbenazine Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Varbenazine Capsules Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Varbenazine Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Varbenazine Capsules Sales Market Share by Manufacturers (2021-2026) Table 27. Global Varbenazine Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Varbenazine Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Varbenazine Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Varbenazine Capsules Manufacturers, Product Type & Application Table 31. Global Varbenazine Capsules Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Varbenazine Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Varbenazine Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Varbenazine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Varbenazine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Varbenazine Capsules Revenue Market Share by Type (2021-2026) Table 38. Global Varbenazine Capsules Revenue Market Share by Type (2027-2032) Table 39. Global Varbenazine Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 41. Global Varbenazine Capsules Sales by Type (2027-2032) & (K Units) Table 42. Global Varbenazine Capsules Sales Market Share by Type (2021-2026) Table 43. Global Varbenazine Capsules Sales Market Share by Type (2027-2032) Table 44. Global Varbenazine Capsules Price by Type (2021-2026) & (US$/Unit) Table 45. Global Varbenazine Capsules Price by Type (2027-2032) & (US$/Unit) Table 46. Global Varbenazine Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Varbenazine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Varbenazine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Varbenazine Capsules Revenue Market Share by Application (2021-2026) Table 50. Global Varbenazine Capsules Revenue Market Share by Application (2027-2032) Table 51. Global Varbenazine Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 53. Global Varbenazine Capsules Sales by Application (2027-2032) & (K Units) Table 54. Global Varbenazine Capsules Sales Market Share by Application (2021-2026) Table 55. Global Varbenazine Capsules Sales Market Share by Application (2027-2032) Table 56. Global Varbenazine Capsules Price by Application (2021-2026) & (US$/Unit) Table 57. Global Varbenazine Capsules Price by Application (2027-2032) & (US$/Unit) Table 58. Lupin Company Information Table 59. Lupin Business Overview Table 60. Lupin Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Lupin Varbenazine Capsules Product Portfolio Table 62. Lupin Recent Development Table 63. Neurocrine Biosciences Company Information Table 64. Neurocrine Biosciences Business Overview Table 65. Neurocrine Biosciences Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Neurocrine Biosciences Varbenazine Capsules Product Portfolio Table 67. Neurocrine Biosciences Recent Development Table 68. Zydus Company Information Table 69. Zydus Business Overview Table 70. Zydus Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zydus Varbenazine Capsules Product Portfolio Table 72. Zydus Recent Development Table 73. Sandoz Company Information Table 74. Sandoz Business Overview Table 75. Sandoz Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sandoz Varbenazine Capsules Product Portfolio Table 77. Sandoz Recent Development Table 78. Teva Pharmaceuticals Company Information Table 79. Teva Pharmaceuticals Business Overview Table 80. Teva Pharmaceuticals Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Teva Pharmaceuticals Varbenazine Capsules Product Portfolio Table 82. Teva Pharmaceuticals Recent Development Table 83. North America Varbenazine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Varbenazine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 86. North America Varbenazine Capsules Sales by Type (2027-2032) & (K Units) Table 87. North America Varbenazine Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 88. North America Varbenazine Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 89. North America Varbenazine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Varbenazine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 92. North America Varbenazine Capsules Sales by Application (2027-2032) & (K Units) Table 93. North America Varbenazine Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 94. North America Varbenazine Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 95. North America Varbenazine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Varbenazine Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. North America Varbenazine Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. North America Varbenazine Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 99. North America Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 100. North America Varbenazine Capsules Sales by Country (2027-2032) & (K Units) Table 101. North America Varbenazine Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 102. North America Varbenazine Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 103. United States Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 104. Canada Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 105. Mexico Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 106. Europe Varbenazine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Varbenazine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 109. Europe Varbenazine Capsules Sales by Type (2027-2032) & (K Units) Table 110. Europe Varbenazine Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 111. Europe Varbenazine Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 112. Europe Varbenazine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Varbenazine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 115. Europe Varbenazine Capsules Sales by Application (2027-2032) & (K Units) Table 116. Europe Varbenazine Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 117. Europe Varbenazine Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 118. Europe Varbenazine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Varbenazine Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. Europe Varbenazine Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. Europe Varbenazine Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 122. Europe Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 123. Europe Varbenazine Capsules Sales by Country (2027-2032) & (K Units) Table 124. Europe Varbenazine Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 125. Europe Varbenazine Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 126. Germany Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 127. France Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 128. U.K. Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 129. Italy Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 130. Russia Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 131. Spain Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 132. Netherlands Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 133. Switzerland Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 134. Sweden Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 135. Poland Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 136. China Varbenazine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 137. China Varbenazine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 138. China Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 139. China Varbenazine Capsules Sales by Type (2027-2032) & (K Units) Table 140. China Varbenazine Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 141. China Varbenazine Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 142. China Varbenazine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 143. China Varbenazine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 144. China Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 145. China Varbenazine Capsules Sales by Application (2027-2032) & (K Units) Table 146. China Varbenazine Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 147. China Varbenazine Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 148. Asia Varbenazine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Varbenazine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 151. Asia Varbenazine Capsules Sales by Type (2027-2032) & (K Units) Table 152. Asia Varbenazine Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 153. Asia Varbenazine Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 154. Asia Varbenazine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 155. Asia Varbenazine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 156. Asia Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 157. Asia Varbenazine Capsules Sales by Application (2027-2032) & (K Units) Table 158. Asia Varbenazine Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 159. Asia Varbenazine Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Asia Varbenazine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Asia Varbenazine Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Asia Varbenazine Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Asia Varbenazine Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 164. Asia Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 165. Asia Varbenazine Capsules Sales by Country (2027-2032) & (K Units) Table 166. Asia Varbenazine Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 167. Asia Varbenazine Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 168. Japan Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 169. South Korea Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 170. India Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 171. Australia Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 172. Taiwan Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 173. Southeast Asia Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 174. SAMEA Varbenazine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 175. SAMEA Varbenazine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 176. SAMEA Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 177. SAMEA Varbenazine Capsules Sales by Type (2027-2032) & (K Units) Table 178. SAMEA Varbenazine Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 179. SAMEA Varbenazine Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 180. SAMEA Varbenazine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 181. SAMEA Varbenazine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 182. SAMEA Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 183. SAMEA Varbenazine Capsules Sales by Application (2027-2032) & (K Units) Table 184. SAMEA Varbenazine Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 185. SAMEA Varbenazine Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 186. SAMEA Varbenazine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. SAMEA Varbenazine Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. SAMEA Varbenazine Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. SAMEA Varbenazine Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 190. SAMEA Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 191. SAMEA Varbenazine Capsules Sales by Country (2027-2032) & (K Units) Table 192. SAMEA Varbenazine Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 193. SAMEA Varbenazine Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 194. Brazil Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 195. Argentina Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 196. Chile Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 197. Colombia Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 198. Peru Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 199. Saudi Arabia Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 200. Israel Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 201. UAE Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 202. Turkey Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 203. Iran Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 204. Egypt Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Table 205. Key Raw Materials Table 206. Raw Materials Key Suppliers Table 207. Varbenazine Capsules Distributors List Table 208. Varbenazine Capsules Customers List Table 209. Research Programs/Design for This Report Table 210. Authors List of This Report Table 211. Secondary Sources Table 212. Primary Sources List of Figures Figure 1. Varbenazine Capsules Image Figure 2. Global Varbenazine Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Varbenazine Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 80mg per Unit Image Figure 5. 60mg per Unit Image Figure 6. 40mg per Unit Image Figure 7. Global Varbenazine Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Varbenazine Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital and Clinic Image Figure 10. Pharmacy Image Figure 11. Other Image Figure 12. Global Varbenazine Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Varbenazine Capsules Revenue (2021-2032) & (US$ Million) Figure 14. Global Varbenazine Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Varbenazine Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Varbenazine Capsules Revenue Market Share by Region (2021-2032) Figure 17. Global Varbenazine Capsules Sales (2021-2032) & (K Units) Figure 18. Global Varbenazine Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Varbenazine Capsules Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Varbenazine Capsules Sales YoY (2021-2032) & (K Units) Figure 21. Europe Varbenazine Capsules Sales YoY (2021-2032) & (K Units) Figure 22. China Varbenazine Capsules Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Varbenazine Capsules Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Varbenazine Capsules Sales YoY (2021-2032) & (K Units) Figure 25. Global Varbenazine Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Varbenazine Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Varbenazine Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Varbenazine Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Varbenazine Capsules Revenue Market Share by Type (2021-2032) Figure 31. Global Varbenazine Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Varbenazine Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Varbenazine Capsules Sales Market Share by Type (2021-2032) Figure 34. Global Varbenazine Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Varbenazine Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Varbenazine Capsules Revenue Market Share by Application (2021-2032) Figure 37. Global Varbenazine Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Varbenazine Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Varbenazine Capsules Sales Market Share by Application (2021-2032) Figure 40. North America Varbenazine Capsules Revenue Share by Type (2021-2032) Figure 41. North America Varbenazine Capsules Sales Share by Type (2021-2032) Figure 42. North America Varbenazine Capsules Revenue Share by Application (2021-2032) Figure 43. North America Varbenazine Capsules Sales Share by Application (2021-2032) Figure 44. North America Varbenazine Capsules Revenue Share by Country (2021-2032) Figure 45. North America Varbenazine Capsules Sales Share by Country (2021-2032) Figure 46. Europe Varbenazine Capsules Revenue Share by Type (2021-2032) Figure 47. Europe Varbenazine Capsules Sales Share by Type (2021-2032) Figure 48. Europe Varbenazine Capsules Revenue Share by Application (2021-2032) Figure 49. Europe Varbenazine Capsules Sales Share by Application (2021-2032) Figure 50. Europe Varbenazine Capsules Revenue Share by Country (2021-2032) Figure 51. Europe Varbenazine Capsules Sales Share by Country (2021-2032) Figure 52. China Varbenazine Capsules Revenue Share by Type (2021-2032) Figure 53. China Varbenazine Capsules Sales Share by Type (2021-2032) Figure 54. China Varbenazine Capsules Revenue Share by Application (2021-2032) Figure 55. China Varbenazine Capsules Sales Share by Application (2021-2032) Figure 56. Asia Varbenazine Capsules Revenue Share by Type (2021-2032) Figure 57. Asia Varbenazine Capsules Sales Share by Type (2021-2032) Figure 58. Asia Varbenazine Capsules Revenue Share by Application (2021-2032) Figure 59. Asia Varbenazine Capsules Sales Share by Application (2021-2032) Figure 60. Asia Varbenazine Capsules Revenue Share by Country (2021-2032) Figure 61. Asia Varbenazine Capsules Sales Share by Country (2021-2032) Figure 62. SAMEA Varbenazine Capsules Revenue Share by Type (2021-2032) Figure 63. SAMEA Varbenazine Capsules Sales Share by Type (2021-2032) Figure 64. SAMEA Varbenazine Capsules Revenue Share by Application (2021-2032) Figure 65. SAMEA Varbenazine Capsules Sales Share by Application (2021-2032) Figure 66. SAMEA Varbenazine Capsules Revenue Share by Country (2021-2032) Figure 67. SAMEA Varbenazine Capsules Sales Share by Country (2021-2032) Figure 68. Varbenazine Capsules Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Varbenazine Capsules Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg per Unit
  • 60mg per Unit
  • 40mg per Unit
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Lupin
  • Neurocrine Biosciences
  • Zydus
  • Sandoz
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Varbenazine Capsules Market by Type
  3. 1.2.1 Global Varbenazine Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 80mg per Unit
  5. 1.2.3 60mg per Unit
  6. 1.2.4 40mg per Unit
  7. 1.3 Varbenazine Capsules Market by Application
  8. 1.3.1 Global Varbenazine Capsules Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital and Clinic
  10. 1.3.3 Pharmacy
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Varbenazine Capsules Market Dynamics
  1. 2.1 Varbenazine Capsules Industry Trends
  2. 2.2 Varbenazine Capsules Industry Drivers
  3. 2.3 Varbenazine Capsules Industry Opportunities and Challenges
  4. 2.4 Varbenazine Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Varbenazine Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Varbenazine Capsules Revenue by Region
  3. 3.2.1 Global Varbenazine Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Varbenazine Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Varbenazine Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Varbenazine Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Varbenazine Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Varbenazine Capsules Sales by Region
  9. 3.4.1 Global Varbenazine Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Varbenazine Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Varbenazine Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Varbenazine Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Varbenazine Capsules Revenue by Manufacturers
  2. 4.1.1 Global Varbenazine Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Varbenazine Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Varbenazine Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Varbenazine Capsules Sales by Manufacturers
  6. 4.2.1 Global Varbenazine Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Varbenazine Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Varbenazine Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Varbenazine Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Varbenazine Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Varbenazine Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Varbenazine Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Varbenazine Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Varbenazine Capsules Market CR5 and HHI
  16. 4.8.2 2025 Varbenazine Capsules Tier 1, Tier 2, and Tier 3
5 Varbenazine Capsules Market by Type
  1. 5.1 Global Varbenazine Capsules Revenue by Type
  2. 5.1.1 Global Varbenazine Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Varbenazine Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Varbenazine Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Varbenazine Capsules Sales by Type
  6. 5.2.1 Global Varbenazine Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Varbenazine Capsules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Varbenazine Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Varbenazine Capsules Price by Type
6 Varbenazine Capsules Market by Application
  1. 6.1 Global Varbenazine Capsules Revenue by Application
  2. 6.1.1 Global Varbenazine Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Varbenazine Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Varbenazine Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Varbenazine Capsules Sales by Application
  6. 6.2.1 Global Varbenazine Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Varbenazine Capsules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Varbenazine Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Varbenazine Capsules Price by Application
7 Company Profiles
  1. 7.1 Lupin
  2. 7.1.1 Lupin Company Information
  3. 7.1.2 Lupin Business Overview
  4. 7.1.3 Lupin Varbenazine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lupin Varbenazine Capsules Product Portfolio
  6. 7.1.5 Lupin Recent Developments
  7. 7.2 Neurocrine Biosciences
  8. 7.2.1 Neurocrine Biosciences Company Information
  9. 7.2.2 Neurocrine Biosciences Business Overview
  10. 7.2.3 Neurocrine Biosciences Varbenazine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Neurocrine Biosciences Varbenazine Capsules Product Portfolio
  12. 7.2.5 Neurocrine Biosciences Recent Developments
  13. 7.3 Zydus
  14. 7.3.1 Zydus Company Information
  15. 7.3.2 Zydus Business Overview
  16. 7.3.3 Zydus Varbenazine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zydus Varbenazine Capsules Product Portfolio
  18. 7.3.5 Zydus Recent Developments
  19. 7.4 Sandoz
  20. 7.4.1 Sandoz Company Information
  21. 7.4.2 Sandoz Business Overview
  22. 7.4.3 Sandoz Varbenazine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sandoz Varbenazine Capsules Product Portfolio
  24. 7.4.5 Sandoz Recent Developments
  25. 7.5 Teva Pharmaceuticals
  26. 7.5.1 Teva Pharmaceuticals Company Information
  27. 7.5.2 Teva Pharmaceuticals Business Overview
  28. 7.5.3 Teva Pharmaceuticals Varbenazine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Teva Pharmaceuticals Varbenazine Capsules Product Portfolio
  30. 7.5.5 Teva Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Varbenazine Capsules Market Size by Type
  2. 8.1.1 North America Varbenazine Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Varbenazine Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Varbenazine Capsules Price by Type (2021-2032)
  5. 8.2 North America Varbenazine Capsules Market Size by Application
  6. 8.2.1 North America Varbenazine Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Varbenazine Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Varbenazine Capsules Price by Application (2021-2032)
  9. 8.3 North America Varbenazine Capsules Market Size by Country
  10. 8.3.1 North America Varbenazine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Varbenazine Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Varbenazine Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Varbenazine Capsules Market Size by Type
  2. 9.1.1 Europe Varbenazine Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Varbenazine Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Varbenazine Capsules Price by Type (2021-2032)
  5. 9.2 Europe Varbenazine Capsules Market Size by Application
  6. 9.2.1 Europe Varbenazine Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Varbenazine Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Varbenazine Capsules Price by Application (2021-2032)
  9. 9.3 Europe Varbenazine Capsules Market Size by Country
  10. 9.3.1 Europe Varbenazine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Varbenazine Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Varbenazine Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Varbenazine Capsules Market Size by Type
  2. 10.1.1 China Varbenazine Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Varbenazine Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Varbenazine Capsules Price by Type (2021-2032)
  5. 10.2 China Varbenazine Capsules Market Size by Application
  6. 10.2.1 China Varbenazine Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Varbenazine Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Varbenazine Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Varbenazine Capsules Market Size by Type
  2. 11.1.1 Asia Varbenazine Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Varbenazine Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Varbenazine Capsules Price by Type (2021-2032)
  5. 11.2 Asia Varbenazine Capsules Market Size by Application
  6. 11.2.1 Asia Varbenazine Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Varbenazine Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Varbenazine Capsules Price by Application (2021-2032)
  9. 11.3 Asia Varbenazine Capsules Market Size by Country
  10. 11.3.1 Asia Varbenazine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Varbenazine Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Varbenazine Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Varbenazine Capsules Market Size by Type
  2. 12.1.1 SAMEA Varbenazine Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Varbenazine Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Varbenazine Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Varbenazine Capsules Market Size by Application
  6. 12.2.1 SAMEA Varbenazine Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Varbenazine Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Varbenazine Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Varbenazine Capsules Market Size by Country
  10. 12.3.1 SAMEA Varbenazine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Varbenazine Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Varbenazine Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Varbenazine Capsules Value Chain Analysis
  2. 13.1.1 Varbenazine Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Varbenazine Capsules Production Mode & Process
  6. 13.2 Varbenazine Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Varbenazine Capsules Distributors
  9. 13.2.3 Varbenazine Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst